Lv1
30 积分 2025-01-15 加入
Mirogabalin: Promising Evidence, Uncertain Access
4天前
已完结
Mirogabalin: Promising Evidence, Uncertain Access
4天前
已完结
Mirogabalin: First Global Approval
5天前
已完结
Bioequivalence and Comparative Pharmacokinetics of Two Generic Mirogabalin Besylate Tablets (5 mg and 10 mg) and Tarlige® in Healthy Chinese Volunteers: A Pooled Analysis of Two Randomized, Open-Label, Two-Period Crossover Studies
3个月前
已完结
皖公网安备34019202002308
